Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

SHA:603718 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	309.98	358.5	140.74	156.55	153.04	18.01
Trading Asset Securities	160.28	158.58	212.48	236.15	385.59	502.73
Cash & Short-Term Investments	470.27	517.08	353.22	392.71	538.63	520.74
Cash Growth	112.60%	46.39%	-10.06%	-27.09%	3.44%	-12.52%
Accounts Receivable	110.2	108.97	84.95	97.41	89.95	59.92
Other Receivables	5.51	2.92	4.91	7.67	31.43	4.83
Receivables	115.71	111.89	89.86	105.08	121.37	64.75
Inventory	61.29	55.01	102.82	144.89	142.62	115.95
Other Current Assets	6.53	7.79	16.65	22.36	172.82	41.06
Total Current Assets	653.79	691.77	562.55	665.03	975.44	742.49
Property, Plant & Equipment	59.42	60.6	164.6	219.45	275.9	434.57
Long-Term Investments	-	-	639.09	315.32	224.7	233.23
Goodwill	1,020	1,006	225.33	224.14	224.14	224.14
Other Intangible Assets	53.38	55.58	38.1	73.56	100.23	109.43
Long-Term Deferred Tax Assets	0.12	0.74	18.6	12.45	8.46	7.93
Long-Term Deferred Charges	16.25	5.92	9.16	3.34	5.32	4.9
Other Long-Term Assets	-	6.52	0.3	0.96	29.91	30.05
Total Assets	1,803	1,827	1,658	1,514	1,844	1,787
Accounts Payable	8.84	6.79	28.56	42.29	39.43	24.24
Accrued Expenses	10.61	25.13	9.52	23.08	32.83	8.2
Short-Term Debt	3	-	270.19	133.39	473.04	466.91
Current Portion of Leases	3.98	3.66	0.83	9.86	2.01	-
Current Income Taxes Payable	6.38	8.76	4.99	24.73	7.81	5.21
Current Unearned Revenue	10.25	9.81	21.61	15.46	32.63	34.59
Other Current Liabilities	42.6	46.09	81.34	71.94	82.22	100.85
Total Current Liabilities	85.66	100.25	417.04	320.75	669.96	640.01
Long-Term Leases	11.2	13.94	-	14.87	2.62	-
Long-Term Unearned Revenue	-	-	64.45	66.26	182.19	183.43
Long-Term Deferred Tax Liabilities	9.1	9.46	1.47	1.37	2.12	1.11
Total Liabilities	105.96	123.65	482.96	403.25	856.9	824.54
Common Stock	655.66	657.9	657.9	644	644	644
Additional Paid-In Capital	277.87	281.86	229.69	139.86	131.57	136.62
Retained Earnings	632.11	663.1	398.41	372.05	250.44	274.93
Treasury Stock	-31.75	-42.38	-66.44	-	-	-
Comprehensive Income & Other	-	-	-2.57	-15.57	-20.41	2.78
Total Common Equity	1,534	1,560	1,217	1,140	1,006	1,058
Minority Interest	163.36	142.72	-42.19	-29.33	-18.41	-96.13
Shareholders' Equity	1,697	1,703	1,175	1,111	987.19	962.2
Total Liabilities & Equity	1,803	1,827	1,658	1,514	1,844	1,787
Total Debt	18.19	17.6	271.02	158.12	477.66	466.91
Net Cash (Debt)	452.08	499.49	82.2	234.59	60.97	53.82
Net Cash Growth	189.40%	507.66%	-64.96%	284.77%	13.27%	-67.87%
Net Cash Per Share	0.70	0.76	0.13	0.37	0.09	0.06
Filing Date Shares Outstanding	655.66	655.66	657.9	644	644	644
Total Common Shares Outstanding	655.66	657.9	657.9	644	644	644
Working Capital	568.13	591.53	145.51	344.28	305.48	102.48
Book Value Per Share	2.34	2.37	1.85	1.77	1.56	1.64
Tangible Book Value	460.25	499.19	953.55	842.63	681.23	724.76
Tangible Book Value Per Share	0.70	0.76	1.45	1.31	1.06	1.13
Buildings	-	23.4	168.06	166.12	289.13	366.9
Machinery	-	42.64	157.38	179.48	231.62	293.63
Construction In Progress	-	12.72	0.75	5.24	2.94	59.69

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.